Celestica, Inc’s recently made public that its Former Officer Agrawal Alok K. acquired Company’s shares for reported $0.44 million on May 30 ’25. In the deal valued at $119.47 per share,3,672 shares were bought.
Then, Laurette Koellner bought 100,000 shares, generating $8,269,000 in total proceeds.
Before that, Laurette T Koellner bought 151,717 shares. Celestica, Inc shares valued at $13,945,827 were divested by the Director at a price of $91.92 per share.
Citigroup initiated its Celestica, Inc [CLS] rating to a Neutral in a research note published on July 21, 2025; the price target was $172. A number of analysts have revised their coverage, including JP Morgan’s analysts, who began to cover the stock in late February with a ‘”an Overweight”‘ rating. CIBC revised its rating on January 31, 2025. It rated CLS as “a Sector outperform” which previously was an “a Neutral”.
Price Performance Review of CLS
On Friday, Celestica, Inc [NYSE:CLS] saw its stock fall -2.56% to $194.74. Over the last five days, the stock has gained 14.40%. Celestica, Inc shares have risen nearly 298.40% since the year began. Nevertheless, the stocks have risen 110.99% over the past one year. While a 52-week high of $214.47 was reached on 07/30/25, a 52-week low of $40.25 was recorded on 04/04/25.
Levels Of Support And Resistance For CLS Stock
The 24-hour chart illustrates a support level at 189.46, which if violated will result in even more drops to 184.19. On the upside, there is a resistance level at 199.33. A further resistance level may holdings at 203.93.
How much short interest is there in Celestica, Inc?
A steep rise in short interest was recorded in Celestica, Inc stocks on 2025-07-15, growing by 0.39 million shares to a total of 4.44 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 4.05 million shares. There was a rise of 8.77%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 22, 2024 when UBS began covering the stock and recommended ‘”a Neutral”‘ rating along with a $95 price target.
